Skip to content

Clinical trials

Terminated Burkitt Lymphoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Status: Terminated Country / region: United States Clear all

113 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20035
20048
20058
20064
20074
200810
20096
201010
20113
20122
20138
20145
20155
20162
20174
20183
20194
20202
20211
20225

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated113

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
M.D. Anderson Cancer Center11
Masonic Cancer Center, University of Minnesota8
Fred Hutchinson Cancer Center7
City of Hope Medical Center6
OHSU Knight Cancer Institute5
Case Comprehensive Cancer Center4
Vanderbilt-Ingram Cancer Center4
Barbara Ann Karmanos Cancer Institute3
University of Medicine and Dentistry of New Jersey3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma113
Precursor Cell Lymphoblastic Leukemia-Lymphoma85
Lymphoma, Large B-Cell, Diffuse79
Lymphoma, Mantle-Cell71
Lymphoma, Follicular68
Leukemia, Lymphocytic, Chronic, B-Cell66
Lymphoma, Non-Hodgkin65
Lymphoma, B-Cell, Marginal Zone63
Lymphoma, Large-Cell, Immunoblastic57
Lymphoma50

Trials

Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.

13 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.